Manufacturing, Characterization and Evaluation of the Effect of Silk Fibroin Membranes, Loaded or Not With Neurotensins on Open Wounds in the Palate: Randomized Clinical Study
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 66
- 试验地点
- 2
- 主要终点
- Change in the Remaining Wound Area (RWA)
研究概览
简要总结
The aim of the present study will be to manufacture and characterize silk fibroin membranes loaded or not with neurotensin and to evaluate clinical, patient-centered and immunological parameters the effect of using these membranes on open wounds on the human palate.
详细描述
Surgical procedures for the reconstruction of gingival and peri-Implant tissues with the purpose of restoring function and aesthetics are commonly used in the dental practice. The use of free gingival graft (FGG), despite being considered the gold standard, causes great morbidity and postoperative pain. Thus, in order to reduce these complications, some biomaterials have been explored to accelerate healing and bring greater comfort to the patient. The present study aims to: 1. manufacture silk fibroin membranes (SF), loaded or not with neurotensin (NT); 2. evaluate, clinically and immunologically, the effect of the membranes on open wounds at palate sites. After the manufacture of the membranes they will be characterized by visual aspect, thickness, mechanical properties, surface texture, water vapor permeability, enzymatic degradation and swelling. Posteriorly, sixty six (n = 66) patients requiring exodontia and ridge preservation for future implant placement will be randomly assigned into three groups: Control - Free Gingival Graft (n = 22): extraction and Free Gingival Graft for sealing the alveolus entrance; Group SF - Fibroin membrane (n = 22): extraction and Free Gingival Graft for sealing the alveolus entrance and placement of the fibroin membrane at the palatal wound site; Group SF + NT - Free Gingival Graft + Neurotensin-loaded Fibroin Membrane (n = 22): extraction and Free Gingival Graft for sealing the alveolus entrance and placement of neurotensin-loaded fibroin membrane at the palatal wound site. The repair of the palatine donor area will be evaluated by clinical parameters such as remaining wound area, tissue thickness, re-epithelialization and early-wound healing index at baseline, 7, 14, 21, 30, 45, and 90 days after the procedure; and patient-centered outcomes by post-operative discomfort, tissue edema and number of analgesic pills used for 14 days after the procedure. In addition, inflammatory cytokines and growth factors will be assessed using the palatal wound inflammatory exudate 3 and 7 days after surgery. For the descriptive statistics, the mean ± standard deviation will be used; Normality: Shapiro-Wilk test; Clinical trials: ANOVA for intra and inter group calculations + Tukey test for multiple comparisons when the Shapiro-Wilk p value ≥ 0.05. If p Shapiro-Wilk <0.05, will be analyzed using the Friedman test (intragroup) and Mann-Whitney tests (intergroup); Parameters centered on patients: T test.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients at least 18 years old, healthy systemically, with good oral hygiene, assessed by means of a plaque index and gingival index less than 25% (O'Leary et al., 1972)
- •Patients with no morphological or pathological changes in the donor palatal region;
- •Patients who have an indication for extraction and with an indication to preserve the socket for future implant installation;
- •The tooth included in the study, as well as the adjacent teeth, must not have loss of periodontal insertion.
排除标准
- •Patients with systemic problems (cardiovascular changes, blood dyscrasias, immunodeficiency, diabetes, among others), who contraindicate the surgical procedure;
- •Patients who use medications that interfere with wound healing;
- •Pregnant or lactating patients;
- •Patients who present opportunistic oral lesions, mainly colonizing the palate region;
- •Smoking patients;
- •Patients undergoing orthodontic treatment;
- •Patients already submitted to periodontal surgery in the area of interest in the present study;
- •Patients with a history of allergy to any type of material used in the present study.
结局指标
主要结局
Change in the Remaining Wound Area (RWA)
时间窗: baseline, 7, 14, 21, 30, 45 and 90 days after surgery
For this, standardized photographs will be taken. As a reference, a scale will be used to measure this area. These photographs will be exported to image software (Image J - National Institute of Health -NIH, Bethesda, USA), the area of the wound will be measured in square millimeters (Dias et al. 2015)
次要结局
- Epithelialization(baseline, 3, 7, 14 and 30 days after the procedure)
- Tissue edema(7 days after the surgical procedure)
- Postoperative discomfort(7, 14, 21, 30, 45 and 90 days after the surgical procedure)
- Number of analgesics(until 14 days after surgery)
- Tissue Thickness(baseline, 45 and 90 days after the procedure)
- Scar and Tissue Colorimetry(7, 14, 21, 30, 45 and 90 postoperative days)
- Early wound healing index(7 and 14 days after surgery)
- Immunologic Analysis - cytokines(3 and 7 days after surgery)
- Immunologic Analysis - matrix metalloproteinases(3 and 7 days after surgery)
- Immunologic Analysis - growth factors(3 and 7 days after surgery)
研究者
Mauro Pedrine Santamaria
Associate Professor
Universidade Estadual Paulista Júlio de Mesquita Filho
